Navigation Links
Warner Chilcott Announces FDA Approval of Next Generation Actonel
Date:10/11/2010

ity and the ability of companies with whom we do business to obtain necessary regulatory approvals; our ability to manage the growth of our business by successfully identifying, developing, acquiring or licensing new products at favorable prices and marketing such new products; our ability to obtain regulatory approval and customer acceptance of new products, and continued customer acceptance of our existing products; changes in tax laws or interpretations that could increase our consolidated tax liabilities; our ability to realize the anticipated opportunities from our acquisition of the global branded pharmaceuticals business from The Procter and Gamble Company; the other risks identified in our periodic filings including our Annual Report on Form 10-K for the year ended December 31, 2009, and from time-to-time in our other investor communications.

We caution you that the foregoing list of important factors is not exclusive.  In addition, in light of these risks and uncertainties, the matters referred to in our forward-looking statements may not occur.  We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as may be required by law.


'/>"/>
SOURCE Warner Chilcott plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent
2. Dr. Mahdi B. Fawzi Joins Warner Chilcott as President, Global Research and Development
3. Warner Chilcott Completes Acquisition of P&Gs Global Branded Prescription Pharmaceuticals Business
4. Warner Chilcott Announces 2010 Financial Guidance Conference Call
5. Warner Chilcott Announces Secondary Equity Offering
6. Warner Chilcott Announces Early Tender Results and Receipt of Consents from a Majority of Holders of its 8-3/4% Senior Subordinated Notes due 2015
7. Warner Chilcott Prices Secondary Equity Offering
8. Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015
9. Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes
10. Warner Chilcott Announces Earnings Release Date and Conference Call For First Quarter 2010 Financial Results
11. Warner Chilcott to Present at the Bank of America Merrill Lynch Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... JERUSALEM , Feb. 27, 2015  Chiasma, ... its lead product for the orphan condition acromegaly, today ... financing round. Participants in the financing included new investors ... blue chip public investment fund, as well as existing ... Abingworth and ARCH Venture Partners. Chiasma ...
(Date:2/26/2015)... DALLAS , February 27, 2015 ... Review, H2 2014 market research report to its ... the Corneal Ulcers, therapeutic pipeline. The ... information on the therapeutic development for Corneal Ulcers. ... infections that includes bacterial infections, viral infections & ...
(Date:2/26/2015)... Ill. , Feb. 26, 2015  Today the ... The psychological and physical side effects of ... that opioid painkillers, such as Vicodin and Oxycontin, are ... "More Americans overdose on prescription painkillers than on heroin ... president and CEO of NSC. "Yet, these medications are ...
Breaking Medicine Technology:Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2
... HOERSHOLM, Denmark and SAN DIEGO, California, October 28 ... Wedel, MD, FACP Joins as Vice President and Chief,Medical Officer ... - Stuart Mackey, JD joins as ... Development for Proprietary RNA-targeted,Locked Nucleic Acid (LNA) Drug Platform , ...
... Incorporated (Nasdaq: VPHM ) reported today its financial results for ... million in net product sales including $29 million in net sales ... net income reached $20 million; Improved working capital to $358 ... including cash and cash equivalents of $289 million; and ...
Cached Medicine Technology:Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs 2Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs 3Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs 4ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 2ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 3ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 4ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 5ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 6ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 7ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 8ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 9ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 10ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 11ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 12ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 13ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 14ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 15
(Date:2/27/2015)... February 27, 2015 Hispanics develop alcoholic ... between four and 12 years earlier than Whites/Caucasians or ... Davis Health System. , While previous research indicated that ... populations, the new study -- published online in the ... to be the first to pinpoint racial and ethnic ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 OnChip ... (IPD), has introduced miniature, wire bondable, silicon ESD (Electrostatic ... LED markets. The ESD88NP and ... away from sensitive LED and IC products. These ... Varistors (MLV). All devices meet the requirements of ...
(Date:2/27/2015)... 27, 2015 Just a little over ... those suffering from Sjögren’s Syndrome after a new autoantibody ... at the University of Buffalo and Immco Diagnostics, Inc. ... was to develop a new diagnostic test ... of new autoantibodies. Researchers aimed to develop a test ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Today, February 27th, ... KAJ Brothers , along with LXR Organics and ... END IT Campaign to raise awareness and promote prevention, rescue ... statistics provided by the END IT Coalition, slavery is the ... year and exists in 167 countries around the world. Slavery ...
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 Clinovo, ... ClinCapture, its validated Electronic Data Capture (EDC) at the ... California on March 2nd and March 3rd at Booth ... self-service platform and DIY CRF and edit-check builder allowing ... in a matter of days, without any programming experience. ...
Breaking Medicine News(10 mins):Health News:UC Davis Study Finds Hispanics Develop Alcoholic Liver Disease at Younger Ages than Caucasians or African Americans 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 3Health News:Breakthrough Blood Test for Early Detection of Sjögren’s Syndrome Now Available 2Health News:KAJ Brothers Join the Campaign to 'End It - Shine A Light On Slavery' 2Health News:Clinovo to Demo Its Self-Service, Cloud-Based EDC Solution at CALBIO2015 on March 2nd and 3rd, 2015 2
... had published a report on a new way to detect ... Harvard Mental Health Letter, tests of // cognitive function are ... people will develop Alzheimer’s. In one study, more than 80% ... test of delayed word recall developed Alzheimer’s over the next ...
... hospitals, a small increase in the malfunction of the ... especially for patients suffering from acute kidney injury (AKI). ... reported these results in the latest issue of the ... researchers had analyzed data on 9,210 hospitalized patients who ...
... undergoing a revolution with increasing importance being given to ... of resources allocated to research in specific genetic disorders. ... to scientists working in the field of genetics but ... acquired new. One such breakthrough has been the successful ...
... for children who suffer from chronic sinusitis only ... suggests that life after surgery for these children ... is the first-line surgical therapy for chronic rhinosinusitis ... also being performed with increased frequency to treat ...
... Cornell University in New York are under investigation for ... false information on protocols with the US National Institutes ... a university research center. , ,Former researcher at ... the clinic to treat her adult patient’s and alleged ...
... is a wrinkle control cream and a potent neurotoxin, ... The product is derived form a bacteria, Clostridium botulinum, ... to note that this form of neurotoxin is playing ... cells. The research is exploring basic nerve cell function, ...
Cached Medicine News:
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: